Skip to main content
$0.81 -$0.05 (-5.3%)

04:00 PM EST on 01/18/22

Protalix Biotherapeutics Inc (NYSEMKT:PLX)

CAPS Rating: No stars

A clinical stage biopharmaceutical company that is focused on developing and manufacturing recombinant therapeutic proteins that are produced through its proprietary plant cell system.

Current Price $0.81 Mkt Cap $0.00
Open $0.85 P/E Ratio 0.00
Prev. Close $0.81 Div. (Yield) $0.00 (0.0%)
Daily Range $0.81 - $0.87 Volume 282,955
52-Wk Range $0.79 - $7.02 Avg. Daily Vol.

Caps

How do you think NYSEMKT:PLX will perform against the market?

Add Stock to CAPS Watchlist

All Players

147 Outperform
72 Underperform
 

All-Star Players

8 Outperform
20 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:PLX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Paul8888888 (< 20)
Submitted January 23, 2016

It is outperforming the market. Volume low. Nobody is panicking.

TMFBiologyFool (61.37)
Submitted May 02, 2012

Low patient numbers + 2 competitors = tough launch.I actually like the manufacturing technology, but next drug is still years away.

NYSEMKT:PLX VS S&P 500 (SPY)

Fools bullish on NYSEMKT:PLX are also bullish on:

Fools bearish on NYSEMKT:PLX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PLX.

Recs

1
Member Avatar Paul8888888 (< 20) Submitted: 1/23/2016 2:31:12 PM : Outperform Start Price: $0.86 NYSE MKT:PLX Score: -147.59

It is outperforming the market. Volume low. Nobody is panicking.

Recs

0
Member Avatar SqwiiTrader (< 20) Submitted: 11/5/2013 2:56:24 PM : Outperform Start Price: $4.40 NYSE MKT:PLX Score: -240.02

IHS pattern

Recs

2
Member Avatar TMFBiologyFool (61.37) Submitted: 5/2/2012 12:24:24 PM : Underperform Start Price: $7.02 NYSE MKT:PLX Score: +313.92

Low patient numbers + 2 competitors = tough launch.

I actually like the manufacturing technology, but next drug is still years away.

Leaderboard

Find the members with the highest scoring picks in PLX.

Score Leader

midastouch017

midastouch017 (< 20) Score: +735.37

For those who believe the biosimilar sector will enjoy a robust bright future, PLX is a wise bet

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
1or5stars 99.56 2/10/2009 Underperform 3W $2.66 -69.38% +438.49% +507.88 0 Comment
anticitradeshort 29.01 4/20/2009 Underperform NS $2.27 -64.12% +439.24% +503.36 0 Comment
Spelunkin 27.39 11/3/2009 Underperform 5Y $10.39 -92.16% +340.05% +432.21 0 Comment
anticitrademix2 < 20 11/2/2009 Underperform 5Y $9.90 -91.77% +338.40% +430.18 0 Comment
anticitrademix < 20 11/2/2009 Underperform 5Y $9.90 -91.77% +338.40% +430.18 0 Comment
ModernDayWarrior 23.53 10/29/2009 Underperform 5Y $9.58 -91.50% +333.99% +425.49 0 Comment
MSFOBV1YH 94.64 11/4/2009 Underperform 5Y $10.93 -92.55% +332.67% +425.22 0 Comment
mathieugp 26.40 9/28/2009 Underperform 3M $7.87 -89.65% +335.39% +425.05 0 Comment
TrackDuality < 20 11/6/2009 Underperform 5Y $11.89 -93.15% +329.62% +422.77 0 Comment
39272x4 < 20 11/9/2009 Underperform 5Y $12.00 -93.21% +322.89% +416.10 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PLX.